SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19.
作者信息
Welsh E, Cardenas-de la Garza J A, Cuellar-Barboza A, Franco-Marquez R, Arvizu-Rivera R I
机构信息
Dermatology Service, Universidad Autónoma de Nuevo León, Hospital Universitario 'Dr José Eleuterio González', Monterrey, NL, México.
Rheumatology Department, Universidad Autónoma de Nuevo León, Hospital Universitario 'Dr José Eleuterio González', Monterrey, NL, México.
出版信息
Br J Dermatol. 2021 Jun;184(6):1194-1195. doi: 10.1111/bjd.19833. Epub 2021 Mar 4.
Abstract
摘要
相似文献
1
SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19.新冠病毒玫瑰糠疹样和荨麻疹样皮疹中严重急性呼吸综合征冠状病毒2刺突蛋白阳性
Br J Dermatol. 2021 Jun;184(6):1194-1195. doi: 10.1111/bjd.19833. Epub 2021 Mar 4.
2
Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions.玫瑰糠疹样皮疹中刺突蛋白免疫组化呈阳性的患者SARS-CoV-2抗体为阴性。
J Eur Acad Dermatol Venereol. 2022 Sep;36(9):e661-e662. doi: 10.1111/jdv.18186. Epub 2022 May 6.
3
Comment on 'Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions'.关于“玫瑰糠疹样皮疹中刺突蛋白免疫组化阳性患者的新冠病毒抗体阴性”的评论
J Eur Acad Dermatol Venereol. 2023 Jan;37(1):e37-e38. doi: 10.1111/jdv.18498. Epub 2022 Aug 25.
4
Authors' reply to comment by Ciccarese et al. regarding 'Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions'.作者对Ciccarese等人就“玫瑰糠疹样皮疹中刺突蛋白免疫组化呈阳性的患者中SARS-CoV-2抗体阴性”的评论的回复。
J Eur Acad Dermatol Venereol. 2023 Jan;37(1):e39-e40. doi: 10.1111/jdv.18546. Epub 2022 Sep 2.
5
Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination.mRNA-1273 COVID-19疫苗接种后不久出现玫瑰糠疹
Int J Infect Dis. 2022 Jan;114:88-89. doi: 10.1016/j.ijid.2021.10.055. Epub 2021 Nov 2.
6
Pityriasis rosea like eruption: A dermatological manifestation of Coronavac-COVID-19 vaccine.玫瑰糠疹样皮疹：科兴新冠疫苗的一种皮肤表现。
Dermatol Ther. 2022 Feb;35(2):e15256. doi: 10.1111/dth.15256. Epub 2021 Dec 26.
7
Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male.一名年轻男性在接种新冠疫苗后出现丘疹水疱样玫瑰糠疹样皮疹。
Dermatol Ther. 2021 Sep;34(5):e15040. doi: 10.1111/dth.15040. Epub 2021 Jun 28.
8
Six cases of pityriasis rosea following SARS-CoV-2 vaccination with BNT162b2.6例接种BNT162b2新冠疫苗后出现玫瑰糠疹的病例。
J Dtsch Dermatol Ges. 2022 Aug;20(8):1123-1124. doi: 10.1111/ddg.14784. Epub 2022 Jun 14.
9
Can COVID-19 cause atypical forms of pityriasis rosea refractory to conventional therapies?新型冠状病毒肺炎（COVID-19）会引发对传统疗法难治的非典型玫瑰糠疹吗？
J Med Virol. 2022 Apr;94(4):1292-1293. doi: 10.1002/jmv.27535. Epub 2021 Dec 31.
10
Pityriasis rosea and COVID-19.玫瑰糠疹与新型冠状病毒肺炎
J Med Virol. 2021 Jul;93(7):4068. doi: 10.1002/jmv.26679. Epub 2020 Dec 1.
引用本文的文献
1
A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination.玫瑰糠疹与SARS-CoV-2/COVID-19感染及疫苗接种的综述
Cureus. 2023 May 9;15(5):e38772. doi: 10.7759/cureus.38772. eCollection 2023 May.
2
Delayed urticaria after BNT162b2 booster vaccination at previous intradermal test site with severe acute respiratory syndrome-coronavirus-2 spike protein.在先前进行严重急性呼吸综合征冠状病毒2刺突蛋白皮内试验的部位接种BNT162b2加强疫苗后出现迟发性荨麻疹。
Asia Pac Allergy. 2022 Jul 18;12(3):e27. doi: 10.5415/apallergy.2022.12.e27. eCollection 2022 Jul.
3
Immunological aspects of COVID-19-related skin manifestations: Revisiting pathogenic mechanism in the light of new evidence.新型冠状病毒相关皮肤表现的免疫学方面：根据新证据重新审视发病机制。
Dermatol Ther. 2022 Oct;35(10):e15758. doi: 10.1111/dth.15758. Epub 2022 Aug 26.
4
The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review.2019年冠状病毒病大流行对皮肤病的影响：一项新颖的全面综述
Dermatopathology (Basel). 2022 Jun 29;9(3):212-243. doi: 10.3390/dermatopathology9030027.
5
Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.新型冠状病毒病 2019 与玫瑰糠疹：免疫关联的综述。
J Dermatol. 2022 Oct;49(10):948-956. doi: 10.1111/1346-8138.16482. Epub 2022 Jun 8.
6
Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis.新冠病毒疫苗接种后皮肤不良反应的全球流行率和临床表现：系统评价和荟萃分析。
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1947-1968. doi: 10.1111/jdv.18294. Epub 2022 Jun 21.
7
Inverse pityriasis rosea secondary to COVID-19 vaccination.新型冠状病毒肺炎疫苗接种继发的反向玫瑰糠疹
Proc (Bayl Univ Med Cent). 2022 Mar 9;35(3):342-343. doi: 10.1080/08998280.2022.2044742. eCollection 2022.
8
Histopathological analysis of skin reactions after coronavirus disease 2019 vaccination: Increment in number of infiltrated plasmacytoid dendritic cell.COVID-19 疫苗接种后皮肤反应的组织病理学分析：浸润性浆细胞样树突状细胞数量增加。
J Dermatol. 2022 Jul;49(7):732-735. doi: 10.1111/1346-8138.16374. Epub 2022 Apr 4.
9
Pityriasis Rosea Induced by COVID-19 Vaccination.新冠疫苗接种诱发的玫瑰糠疹
Eur J Case Rep Intern Med. 2022 Feb 3;9(2):003164. doi: 10.12890/2022_003164. eCollection 2022.
10
An Efficient Stacked Deep Transfer Learning Model for Automated Diagnosis of Lyme Disease.一种用于莱姆病自动诊断的高效堆叠深度迁移学习模型。
Comput Intell Neurosci. 2022 Feb 28;2022:2933015. doi: 10.1155/2022/2933015. eCollection 2022.
本文引用的文献
1
Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19.新型冠状病毒肺炎期间玫瑰糠疹患者中人类疱疹病毒6型、7型及EB病毒的激活情况
J Med Virol. 2021 Apr;93(4):1850-1851. doi: 10.1002/jmv.26549. Epub 2020 Oct 7.
2
Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID-19 pandemic.在 COVID-19 大流行时代，皮肤科门诊疾病发病模式的相对变化。
Dermatol Ther. 2020 Nov;33(6):e14096. doi: 10.1111/dth.14096. Epub 2020 Aug 14.
3
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19.SARS-CoV-2 刺突蛋白的结构和功能特性：COVID-19 的潜在抗病毒药物研发。
Acta Pharmacol Sin. 2020 Sep;41(9):1141-1149. doi: 10.1038/s41401-020-0485-4. Epub 2020 Aug 3.
4
SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.SARS-CoV-2 内皮感染导致 COVID-19 冻疮样皮疹：7 例儿科病例的组织病理学、免疫组织化学和超微结构研究。
Br J Dermatol. 2020 Oct;183(4):729-737. doi: 10.1111/bjd.19327. Epub 2020 Aug 5.
5
Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?新型冠状病毒肺炎感染中的荨麻疹性血管炎：一种与血管病相关的症状？
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e566-e568. doi: 10.1111/jdv.16713. Epub 2020 Jun 26.
Zotero 插件